Twin Tree Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-2,569
Closed -$222K – 1340
2018
Q3
$298K Buy
2,569
+1,855
+260% +$209K ﹤0.01% 892
2018
Q2
$90K Buy
+714
New +$86.9K ﹤0.01% 1040
2016
Q4
– Sell
-598
Closed -$65K – 1182
2016
Q3
$65K Sell
598
-3,670
-86% -$423K ﹤0.01% 1018
2016
Q2
$529K Buy
+4,268
New +$515K 0.01% 820
2016
Q1
– Sell
-672
Closed -$73K – 1257
2015
Q4
$73K Sell
672
-14,343
-96% -$1.64M ﹤0.01% 1238
2015
Q3
$1.5M Buy
15,015
+14,209
+1,763% +$1.55M 0.04% 421
2015
Q2
$92K Buy
806
+675
+515% +$81.8K ﹤0.01% 1166
2015
Q1
$14K Sell
131
-10,415
-99% -$1.11M ﹤0.01% 1092
2014
Q4
$1.27M Buy
10,546
+7,398
+235% +$972K 0.04% 523
2014
Q3
$461K Buy
+3,148
New +$486K 0.01% 725

Other funds holding CLB

Twin Tree Management's CLB Position: Q4 2018 in Review

Twin Tree Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,569 shares — an estimated $222K sold.

Twin Tree Management first reported a position in CLB in Q3 2014 and held it in 10 quarters. The position peaked at $1.5M in Q3 2015. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Twin Tree Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Twin Tree Management sold 2,569 Core Laboratories shares in Q4 2018, an estimated $222K.
  • Twin Tree Management first reported a position in Core Laboratories in Q3 2014 and held it in 10 quarters.
  • Twin Tree Management's Core Laboratories position peaked at $1.5M in Q3 2015.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Twin Tree Management's 13F filing for Q4 2018, filed 13 Feb 2019.